Takeda Pharmaceutical Li... (TKPHF)

PNK: TKPHF · Real-Time Price · USD

29.85

-2.28 (-7.10%)

At close: Apr 30, 2025, 3:48 PM

Takeda Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	4,579B	4,546.1B	4,413.1B	4,263.8B	4,169B	4,154.4B	4,113.6B	4,027.5B	3,944.6B	3,749.4B	3,591.9B	3,569B	3,466B	3,401.4B	3,345.6B	3,197.8B	3,199.2B	3,221.8B	3,243.9B	3,291.2B	3,236.7B	2,876.8B	2,496.5B	2,097.2B	1,781B	1,769.7B	1,772.1B	1,770.5B	1,785.8B	1,762.7B	1,746.3B	1,732B	1,730B	1,754.1B	1,795.1B	1,807.4B	1,831.1B	1,830.5B	1,813B
Cost of Revenue	1,743.5B	1,706.1B	1,655.3B	1,426.7B	1,353.9B	1,310.4B	1,272.3B	1,244.1B	1,242.7B	1,188.1B	1,158.5B	1,106.8B	1,051.9B	1,023.6B	997.49B	994.31B	989.04B	1,015.5B	1,037.5B	1,100.1B	1,141.7B	1,000.7B	839.69B	659.69B	480.75B	484.52B	495.64B	495.92B	519.43B	524.64B	544.23B	558.75B	557.31B	554.85B	549.68B	535.4B	537.02B	531.42B	524.07B
Gross Profit	2,835.6B	2,840B	2,757.8B	2,837.1B	2,815.1B	2,844B	2,841.3B	2,783.4B	2,701.9B	2,561.2B	2,433.4B	2,462.2B	2,414.1B	2,377.8B	2,348.1B	2,203.5B	2,210.2B	2,206.3B	2,206.4B	2,191.1B	2,095B	1,876.1B	1,656.8B	1,437.5B	1,300.2B	1,285.2B	1,276.5B	1,274.6B	1,266.3B	1,238B	1,202.1B	1,173.3B	1,172.7B	1,199.3B	1,245.4B	1,272B	1,294.1B	1,299.1B	1,288.9B
Operating Income	604.8B	642.77B	409.18B	411.42B	312.71B	354.78B	508.56B	490.5B	400.32B	369.82B	362.81B	460.84B	613B	639.66B	590.54B	509.27B	296.59B	206.96B	199.1B	41.69B	24.37B	83.32B	115.97B	204.97B	203.92B	179.4B	145.68B	241.79B	260.72B	228.14B	197.91B	155.87B	180.78B	182.45B	234.2B	130.83B	-160.83B	-135.5B	-143.38B
Interest Income	33.8B	62.57B	67.82B	63.59B	65.39B	85.28B	90.7B	125.17B	117.39B	79.85B	71.93B	56.86B	104.35B	128.61B	131.76B	105.52B	58.03B	63.83B	62.51B	51.57B	51.57B	22.77B	16.54B	14.1B	31.93B	34.12B	32.27B	39.54B	25.2B	21.48B	23.3B	12.28B	13.16B	13.62B	19.97B	21.65B	17.71B	18.19B	15.55B
Pretax Income	231.12B	265.97B	50.62B	49.05B	148.23B	194.12B	354.65B	375.09B	273.13B	238.17B	235.07B	302.57B	487.5B	525.1B	458.92B	366.24B	118.59B	33.64B	36B	-119.48B	-116.2B	-93.44B	-24.15B	94.9B	137.69B	145B	112.83B	217.21B	222.42B	221.32B	191.91B	143.35B	174.75B	173.52B	221.49B	120.54B	-178.4B	-156.53B	-156.71B
Net Income	208.06B	290B	149.92B	144.07B	178.22B	191.63B	301.4B	317.02B	274.52B	213.17B	197.39B	230.06B	438.52B	473.11B	431.18B	376B	180.63B	56.05B	105.86B	2.69B	-54.34B	15.64B	10.22B	109.13B	110.41B	140.74B	120.34B	186.89B	190.17B	163.46B	160.2B	114.94B	132.19B	150.08B	155.11B	80.17B	-111.88B	-152.83B	-154.59B
Selling & General & Admin	1,094.1B	1,091.1B	1,075.7B	1,053.8B	1,023.4B	1,018.2B	1,013.9B	997.31B	965.94B	934.72B	898B	886.36B	897.32B	888.89B	893.13B	875.66B	894.33B	920.9B	927.9B	964.74B	981.6B	886.28B	811.78B	717.6B	619.44B	624.63B	627.27B	628.11B	636.03B	625.38B	619.97B	619.06B	614.62B	628.22B	634.03B	650.77B	650.1B	642.96B	637.73B
Research & Development	710.08B	727.26B	735.65B	729.92B	695.01B	682.26B	652.46B	633.33B	616.01B	569.76B	547.21B	526.09B	495.75B	484.94B	471.49B	455.83B	481.85B	487B	482.34B	492.38B	492.48B	447.23B	413.2B	368.3B	317.68B	321.78B	321.72B	325.44B	325.16B	315.43B	311.44B	312.3B	315.83B	336.52B	341.49B	345.93B	386.77B	386.95B	387.93B
Other Expenses	589.38B	368.64B	215B	-1.21B	-1.21B	-1.01B	-1.01B	-1.01B	-1.01B	n/a	-1.52B	-1.52B	-1.52B	-1.52B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2,393.6B	2,398.6B	2,549.9B	2,464.2B	2,540.9B	2,489.2B	2,332.8B	2,292.9B	2,301.6B	2,191.4B	2,070.6B	2,001.3B	1,801.1B	1,738.1B	1,757.5B	1,694.2B	1,913.6B	1,999.4B	2,007.3B	2,149.4B	2,115.2B	1,837.4B	1,585.5B	1,277.2B	1,096.3B	1,105.8B	1,130.8B	1,032.8B	1,005.6B	1,009.9B	1,004.1B	1,017.4B	991.88B	1,016.8B	1,011.2B	1,141.1B	1,454.9B	1,434.6B	1,432.3B
Interest Expense	206.93B	241.9B	219.97B	219.85B	215.6B	228.78B	236.06B	231.95B	189.02B	155.98B	141.85B	157.45B	232.69B	248.66B	272.85B	248.63B	234.31B	215.38B	204.71B	203.93B	167.95B	146.49B	102.39B	71.12B	55.34B	39.85B	36.76B	31.93B	29B	28.11B	27.84B	23.25B	18.36B	20.73B	31.5B	31.93B	35.74B	40.47B	30.09B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	121.06B	121.06B	121.06B	121.06B	113.21B	113.21B	113.21B
Cost & Expenses	3,974.2B	3,941.8B	4,042.5B	3,890.8B	3,894.8B	3,799.6B	3,605.1B	3,537B	3,544.3B	3,379.5B	3,229.1B	3,108.2B	2,853B	2,761.8B	2,755B	2,688.5B	2,902.6B	3,014.8B	3,044.8B	3,249.5B	3,256.9B	2,838.1B	2,425.2B	1,936.9B	1,577.1B	1,590.3B	1,626.4B	1,528.7B	1,525B	1,534.5B	1,548.4B	1,576.2B	1,549.2B	1,571.7B	1,560.9B	1,676.6B	1,991.9B	1,966B	1,956.4B
Income Tax Expense	26.61B	-20.45B	-95.73B	-91.41B	-30.1B	2.4B	53.23B	58.05B	-1.4B	24.97B	37.6B	72.41B	48.81B	51.8B	27.54B	-9.94B	-61.99B	-22.4B	-69.89B	-122.21B	-62.03B	-109.25B	-34.45B	-14.12B	27.32B	4.47B	-6.97B	30.5B	34.25B	58.74B	31.75B	27.83B	39.6B	20.42B	63.1B	37.06B	-69.38B	-6.33B	-4.79B
Shares Outstanding (Basic)	1.58B	1.58B	1.59B	1.57B	1.57B	1.57B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.57B	1.57B	1.55B	1.57B	1.56B	1.56B	1.56B	1.57B	1.56B	1.56B	1.55B	1.5B	784.48M	784.44M	782M	781.23M	781.11M	780.94M	780.07M	780M	780.79M	780.99M	781.83M	779.04M	783.45M	783.44M	784.9M
Shares Outstanding (Diluted)	1.61B	1.61B	1.59B	1.57B	1.59B	1.57B	1.57B	1.61B	1.57B	1.56B	1.55B	1.55B	1.57B	1.58B	1.55B	1.57B	1.58B	1.57B	1.57B	1.57B	1.56B	1.56B	1.56B	1.5B	788.46M	787.68M	786.46M	781.23M	786.34M	785.76M	785.23M	780M	784.64M	783.71M	785.22M	779.07M	790.03M	790.29M	789.94M
EPS (Basic)	131.19	183.54	94.72	92.29	114.24	123.49	193.94	204.35	177.01	137.29	126.76	147.92	280.42	302.59	275.93	239.78	115.69	35.93	67.91	1.69	-36.39	32.43	59.60	172.94	140.77	179.80	153.96	239.52	243.63	209.45	205.28	146.97	169.03	191.68	198.00	102.02	-141.96	-194.3	-196.66
EPS (Diluted)	129.97	181.89	94.04	91.22	112.43	121.59	191.75	202.19	175.59	136.41	126.01	147.03	279.52	301.45	274.94	239.04	114.96	35.67	67.57	1.66	-36.42	32.16	59.17	171.89	139.72	178.41	152.60	237.50	241.61	207.75	203.69	146.05	168.12	190.40	196.50	100.87	-143.12	-194.89	-197
EBITDA	1,095.9B	1,142.9B	895.97B	859.32B	1,025.5B	1,057.4B	1,196.3B	1,171.4B	1,040.5B	980.36B	946.17B	1,014.7B	1,020.4B	1,039.5B	988.68B	890.19B	817.22B	732.66B	833.96B	864.69B	859.96B	798.33B	622.28B	441.23B	384.78B	383.58B	348.65B	460.04B	483.24B	444.3B	438.37B	380.99B	384.23B	395.07B	430.37B	332.14B	65.55B	123.22B	119.26B
EBIT	341.47B	411.3B	185.51B	183.83B	322.6B	381.68B	537.99B	554.32B	441.04B	373.04B	355.81B	438.91B	568.19B	621.75B	579.77B	462.87B	317.04B	213.15B	228.26B	107.31B	92.17B	93.47B	95.24B	147.71B	193.04B	211.1B	174.45B	274B	276.29B	248.04B	219.75B	166.6B	193.12B	194.25B	253B	152.47B	-142.66B	-116.07B	-126.62B
Depreciation & Amortization	758.37B	758.48B	748.72B	728B	702.67B	692.49B	677.62B	664.4B	655.26B	625.67B	598.49B	583.15B	503.75B	496.22B	494.51B	493.15B	496.45B	501.53B	505.27B	514.1B	555.53B	449.04B	345.77B	233.92B	170.67B	175.91B	174.69B	182.13B	203.04B	200.68B	224.98B	222.79B	199.51B	208.68B	192.23B	197.38B	225.92B	258.26B	262.18B